Loading...
This year, our list of NEJM Journal Watch Oncology and Hematology top stories includes coverage of studies on breast, lung, gastrointestinal, and genitourinary cancers as well as malignant and benign hematology. These summaries underscore our goal of identifying the most clinically relevant trials and highlighting their key findings and implications. We look forward to continuing to bring you concise summaries of the most important research in oncology and hematology during the coming year.
Our oncology and hematology top 10 stories of 2021 are as follows:
OlympiA: Game Changer for Breast Cancer Treatment
Clinical and Pathologic Factors Matter in Decision Making for Breast Cancer Care
Sotorasib for KRAS G12C Mutant Non−Small-Cell Lung Cancer
USPSTF Expands Its Recommendation for Lung Cancer Screening with Low-Dose Computed Tomography
Adding First-Line Nivolumab to Chemotherapy for Gastroesophageal Adenocarcinoma
Adjuvant Nivolumab in Esophageal Cancer
Cabozantinib plus Nivolumab Improves Overall Survival in Advanced Kidney Cancer
Further Information on Immune Thrombotic Thrombocytopenia Following SARS-CoV-2 Vaccination